Product Images Dutasteride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Dutasteride NDC 0115-1438 by Impax Generics, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Dutasterided Structure - dutasteride capsules 1

0.5mg-90ct - dutasteride capsules 10

Figure 1 AUA-SI Scorea Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 2

The text describes a chart or graph that represents the mean change from baseline in AUA-SI (American Urological Association Symptom Index) over a period of 18 months of treatment. The horizontal axis indicates the months of treatment, while the vertical axis represents the mean change value. The chart includes data for both a placebo group and a group treated with dutasteride.*

Figure 2 Percent of Subjects Developing Acute Urinary Retention Over a 24-Month Period (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 3

This appears to be a chart displaying data related to the percentage of patients in the Placebo group and Dutasterie group over the course of several months of treatment. The chart shows the number of events at each stage and the cumulative percentage of patients. However, without additional context or information it is difficult to interpret the data or provide any additional insights.*

Figure 3 Percent of Subjects Having Surgery for Benign Prostatic Hyperplasia Over a 24-Month Period (Randomized, Double-Blind, Placebo-Controlled Studies Pooled - dutasteride capsules 4

Figure 4 Prostate Volume Percent Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 5

Figure 5 Qmax Change from Baseline (Randomized, Double-Blind, Placebo-Controlled Studies Pooled) - dutasteride capsules 6

Figure 6 International Prostate Symptom Score Change From Baseline Over a 48-Month Period (Randomized, Double-Blind, Parallel Group Study [CombAT Study]) - dutasteride capsules 7

Figure 7 Qmax Change From Baseline Over a 24-Month Period (Randomized, Double-Blind, Parallel Group Study [CombAT Study]) - dutasteride capsules 8

0.5mg-30ct - dutasteride capsules 9

This appears to be a medication label for Dutasteride capsules, with dosage information and warnings about who should use the medication. It also includes specific information about the product, including its NDC number, lot number and an expiration date. The label cautions that these capsules should not be used by women or children and includes a warning about potential contact with leaking capsules, advising users to wash it immediately with soap and water.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.